RATIONALE-BASED DESIGN OF A TARGETED THERAPY FOR CANCER

• 收藏
• 分享

专利权人:

Celestra Life Science LLC

发明人:

申请号：

EP14867137.3

公开号：

EP3077544B1

申请日:

2014.03.12

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

Method, composition and kit of the invention be related to finding,I.e. Lestaurtinib reduces horizontal and approach active SPOP substrates. Therefore, one or more SPOP in method described herein and composition inhibit the reaction to stimulation, for crystalline substrate or signaling approach activity and its in object in need.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/